“fda” Archives

in
Entry Author Date Location
Eleven Bio’s Eye Disease Drug Set For $22.5M Milestone from Roche 07/08/16 Boston
Austin’s Stellarray Tackles Radiography in Space for NASA Project 07/08/16 Texas
Biotech Roundup: Fighting Addiction, Obama Precision, Juno Deaths & More 07/08/16 National
After Three Deaths, FDA Halts Juno’s Leading CAR-T Trial 07/07/16 Seattle
Pernix Therapeutics Slashes Staff to Shake Up Sales Strategy 07/07/16 New York
Recruitment Goal In Obama Precision Med Study: 1M in 3 or 4 Years 07/06/16 National
Amicus Takes Aim at Rare Brain Disorder with MiaMed Acquisition 07/06/16 New York
San Antonio’s Invictus Medical Board Member Replaces Roberts as CEO 07/06/16 Texas
With CF Pact, Moderna and Vertex Aim to Spray mRNA Into the Lungs 07/06/16 Boston
Bristol-Myers Squibb Boosts Cancer Drug Pipeline with Cormorant Deal 07/05/16 New York
Alnylam Advances RNAi Drug Results After Two Years of Treatment 07/01/16 Boston
Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More 07/01/16 National
Bone-Healing Therapies Firm Bioventus Files for IPO 06/30/16 Raleigh Durham
Riding Moonshot, FDA Will Revamp Its Cancer Practice. To What End? 06/30/16 National
More Job Cuts at Infinity As AbbVie Sends Back Blood Cancer Drug 06/28/16 Boston
Amid Brexit Fallout, U.K.-Listed PureTech Debuts Speech Diagnosis Firm 06/28/16 Boston
Regulus Shares Crumble As FDA Halts Testing of Hepatitis C Drug 06/27/16 San Diego
Biotech Roundup: CRISPR’s 1st Trial, IPO Insiders, Zika & More 06/24/16 National
EndoCyte’s Ellis Out as CEO, Sherman Appointed to Top Spot 06/20/16 Indiana
OrthoPediatrics Bones Up on IPO for Children’s Medical Devices 06/20/16 Indiana
Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More 06/17/16 National
Struggling Aegerion, QLT to Merge, Change Name to Novelion 06/15/16 Boston
Infinity Closes Research Ops as Blood Cancer Drug Comes Up Short 06/14/16 Boston
Alpine Immune Sciences, Former Dendreon CEO’s Latest Startup, Gets $48M 06/13/16 Seattle
Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More 06/10/16 National
Ocular’s Shares Fall After Eye Treatment Fails Latest Test 06/06/16 Boston
Biotech Roundup: Deals Gone Wrong, Ethical Red Flags & Bay Goodbyes 06/03/16 National
Two Years After Paying $680M, BioMarin Shelves Duchenne Drug 05/31/16 San Francisco
Texas Roundup: Tech Wildcatters, Funds for eyeQ & EquipmentShare, VR 05/31/16 Texas
Intercept’s Liver Drug Wins FDA Approval To Treat Rare Disease 05/28/16 New York
Page 4 of 55 « previous page · next page »